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wall/sternum. It is determined by calculating the difference 
between registration results of the two areas, both for 
translations and rotations. For registration of the 
supraclavicular lymph node area the trachea was used as a 
surrogate. Registration of this area was performed using a 
grey-value algorithm.  
The systematic and random error and group mean of the 
lymph node position was calculated for both groups. T-test 
was performed to determine significant difference between 
the mean of both groups. 
Results: 
 
Results are presented in table 1.  
This study shows no significant differences between the set-
up accuracy of both groups. 
The systematic translation error in the cranial-caudal 
translation is the largest for both patient groups. 
The systematic error of the left-right, cranial-caudal and 
anterior-posterior rotations didn't show a significantly smaller 
rotational error in the supra clavicular area for the group 
with the chin fixation. 
Conclusions: The addition of chin fixation doesn't improve 
the stability of the supraclavicular lymph node area, nor does 
it prevent great deviations in individual patient set-up. 
Limitations of the current study could be the small sample 
size, the learning curve in the fabrication of the chin fixation 
and its use.  
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Purpose/Objective: External radiotherapy after surgery is 
considered standard for breast conserving treatment. In some 
patients, boost over the breast region at risk for local 
recurrences can be administered sequentially or concomitant 
(simultaneous integrated boost: SIB) with whole breast 
irradiation. This SIB technique reduces the total time of 
treatment and sometimes determines best dose 
homogeneity. Acute cutaneous toxicity is due to the 
cumulative dose and dose per fraction administered, so it can 
be thought that SIB increases this side-effect.  
Our objective was to evaluate acute skin toxicity in 
radiotherapy breast cancer and differences between 
concomitant and sequential boost. 
Materials and Methods: We analyzed 160 patients with 
breast conserving treatment, aged from 33 to 80 years. 
Radiation treatment was delivered with Linear Accelerator 
and 3D-planning. Planning Target Volumes and doses were: 
PTV1: 50Gy whole breast + PTV2 (boost): 10-14Gy with two 
different techniques: sequential or concomitant (SIB). 
Skin toxicity was assessed weekly using the RTOG scale. 
Results: Radiation boost: SIB was applied in 65 patients 
(40.3%); Sequential boost in 95 patients (59.75%) 
Skin Toxicity : Global Grade I radiodermitis was evaluated in 
86 patients (54.1%); Grade II in 72 patients (45.3%); Grade III 
only in 1 patient (0.61%) 
According to the boost technique: (fig.1) 
-SIB: Gr I, 38 pts (58.4% of this group); Gr II, 27 pts (41.5%). 
No grade III toxicity was assessed. 
-Sequential boost: Gr I, 48pts (50.5% of this group); Gr II/III, 
47 pts (49.4%) 
Differences in grade I toxicity SIB vs sequential were not 
statistically significant: p=0.41; and differences in grade 
II/III, neither were statistically significant: p=0.27 
 
Fig.1. RTOG toxicity and boost technique 
 
Conclusions: In our Institution, acute skin toxicity in external 
radiotherapy with boost for breast cancer is mild, with less 
than 1% of grade III complications.  
There are a greater number of patients with grade I and 
grade II/III in sequential boost vs SIB, but these differences 
were not statistically significant so we can conclude that 
Simultaneous Integrated Boost does not increase acute 
cutaneous toxicity, and reduces the overall duration of 
treatment.  
One more in-depth analysis of the data and other parameters 
(irradiated volume, dosimetry,…) could confirm this results or 
stablish differences in toxicity between these two 
techniques. 
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Purpose/Objective: Most local recurrences occur in or near 
the tumor bed after breast-conserving therapy (lumpectomy 
followed by whole breast irradiation (WBRT)). Tracking the 
boost volume instead of the thoracic wall using implanted 
surgical clips might reduce RT planning margins. In this study, 
the accuracy of surgical clip matching on conebeam CT 
(CBCT) and the relative motion of the clip area relative to 
the thoracic wall was investigated. 
Materials and Methods: The accuracy of the clip matching 
was studied by determination of the interobserver variation 
using the standard deviation of the X, Y and Z-direction in all 
matches. In a group of 20 breast cancer patients, 5 to 8 
CBCT's were acquired (128 scans in total). During surgery 2 to 
5 clips were implanted with a median of 4 clips per patient. 
Each CBCT was registered by 3 or 4 Radiation Therapy 
Technicians (RTTs) to the planning CT in XVI software (Elekta 
AB) resulting in 484 independent registrations (on average 3.8 
per scan). For registration, a clipbox encompassing the clips 
area was defined. Next, the automatic seed match option 
